文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

2017年印度孕妇风疹血清阳性率调查

Sero-prevalence of rubella among pregnant women in India, 2017.
PubMed 文献 · Vaccine · 2018-11-15

该研究在印度六家产前门诊哨点医院系统抽样1800名孕妇,检测风疹IgG抗体。83.4%为血清阳性,15.2%为阴性,1.3%为不确定;亚样本中87.8%抗体浓度≥10 IU/mL。结论指出孕妇风疹血清阳性率高,在无常规儿童免疫情况下高血清阳性率提示风疹病毒持续传播。

要点

  • 印度六家哨点医院孕妇风疹IgG血清阳性率为83.4%。
  • 15.2%孕妇风疹IgG阴性,为易感人群。
  • 血清阳性率不随年龄、教育程度或居住地变化。

核心结论

  • 孕妇风疹血清阳性率高,但在无常规儿童免疫情况下,高血清阳性率提示风疹病毒在城市哨点地区持续传播。

研究设计与样本

  • 在印度六家产前门诊哨点医院系统抽样1800名孕妇,检测风疹IgG抗体,并按说明书分类为血清阳性(滴度≥10 IU/ml)、血清阴性(滴度<8 IU/ml)或不确定(滴度8-9.9 IU/ml);在亚样本中估计IgG抗体滴度。

主要发现

  • 1800份血清中,1502份(83.4%)为血清阳性,24份(1.3%)为不确定,274份(15.2%)为血清阴性。
  • 风疹血清阳性率不因年龄组、教育状况或居住地而异。

关键数值与推荐

  • 血清阳性定义为IgG滴度≥10 IU/ml,血清阴性为<8 IU/ml,不确定为8-9.9 IU/ml。
  • IgG滴度≥10 IU/mL被视为具有保护性。

临床怎么用

  • 在产前保健中可参考风疹血清阳性率数据评估孕妇易感性,血清阴性孕妇需关注风疹感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We conducted a sero-survey among pregnant women attending antenatal clinics of six hospitals which also function as sentinel sites for CRS surveillance, to estimate the prevalence of IgG antibodies against rubella. METHODS: We systematically sampled 1800 pregnant women attending antenatal clinics and tested their sera for IgG antibodies against rubella. We classified sera as seropositive (titre ≥10 IU/ml), sero-negative (titre <8 IU/ml) or indeterminate (titre 8-9.9 IU/ml) per manufacturer's instructions. In a sub-sample, we estimated the titers of IgG antibodies against rubella. IgG titer of ≥10 IU/mL was considered protective. RESULTS: Of 1800 sera tested, 1502 (83.4%) were seropositive and 24 (1.3%) were indeterminate and 274 (15.2%) were sero-negative. Rubella sero-positivity did not differ by age group, educational status or place of residence. Three hundred and eighty three (87.8%) of the 436 sera had IgG concentrations ≥10 IU/mL. CONCLUSION: The results of the serosurvey indicate high levels of rubella sero-positivity in pregnant women. High sero-prevalence in the absence of routine childhood immunization indicates continued transmission of rubella virus in cities where sentinel sites are located.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Muliyil DE, Singh P, Jois SK, et al. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine. 2018. PMID: 30448333. doi:10.1016/j.vaccine.2018.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。